An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD
An Efficacy Study of Benzalkonium Chloride Solution Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD
An Efficacy Study of Benzalkonium Chloride Solution Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD
Sponsor study identifier
interventional
60
0 countries
N/A
Study Start
October 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of study is to evaluate the efficacy and safety of Benzalkonium Chloride Solution clearing the oral colonized bacterium in hospitalized patients with COPD.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2014
Date type not reportedThis date has not been verified as actual or estimated.
October 17, 2014
Actual (reported)October 21, 2014
Actual (reported)July 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Aerobic pathogenic bacterial colonization rate in oral airway
Day 7
The improvement of oral status
Day 7
The subjective feeling
Day 7
The incidence of hospital acquired respiratory infections
Day 7
Tid, for 7 days.
Tid, for 7 days.
Tid, 7 days
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Formulated product
Benzalkonium chloride solution
The registry describes a specific formulation. Its exact chemical ingredients and approval status require separate evidence.
View registry recordThe registry names these ingredients. The formulation’s exact chemical form has not been confirmed.
Benzalkonium chloride solution
Named ingredient: Benzalkonium chloride
View registry recordShiyue Li, Professor
The First Affiliated Hospital of Guangzhou Medical University
First Submitted
October 17, 2014
First Posted
October 21, 2014
Study Start
October 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2015
Estimated (date passed)Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2015
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 21, 2014
Record last verified: 2014-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: